What are outcome-based payment agreements or VBAs, and how can MDs develop innovative financing models? What do the next few years hold for VBAs in therapeutics and diagnostics? How can we mentor young doctors looking to venture off the beaten path? Join us as Dr. Micahel Sherman answers these questions and discusses mentorship, supporting VBAs, the Inflation Reduction Act, and many other topics.

Michael is currently a Venture Partner at RA Capital. Michael is formerly an executive vice president and the chief medical officer at Point32Health, formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan. Michael is known as a pioneer in developing outcomes-based payment agreements and bringing novel interventions to patients. He signed the first outcomes-based contract for a gene therapy in the US.

Michael holds an M.D. from Yale University, an MBA from Harvard Business School, and master’s and bachelor’s degrees from the University of Pennsylvania.

We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!